HC Wainwright Reaffirms Buy Rating for Anixa Biosciences (NASDAQ:ANIX)
Anixa Biosciences (NASDAQ:ANIX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They presently have a $7.00 price objective on the stock. HC Wainwright’s price target points to a potential upside of 122.22% from the company’s previous close. HC Wainwright […]
